Press Releases

BERGEN, Norway, Nov. 7, 2019 /PRNewswire/ -- BerGenBio ASA (OSE:BGBIO), will announce its results for the third quarter on Tuesday 19 November 2019. A presentation by BerGenBio's senior management team will take place at 10am CET at:Arctic Securities Haakon VIIs gate 5

OSLO, Norway, Nov. 7, 2019 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its third quarter 2019 results.A meeting for investors, analysts and press will take place in Oslo today at 1

SUZHOU, China, Nov. 6, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that an abstract on the CS1001-201 trial (Abstract #2833) was accepted by the 2019 American Society of Hematology (ASH) Annual Meeting and has been published online yesterday on the meeting's official website. Additionally, the Company will release f

MIAMI GARDENS, Fla., Nov 6, 2019 /PRNewswire/ -- Skin & Cancer Associates (SCA), the first dermatology practice management group in Florida, is excited to announce the dermatology practice and research institute of Dr. Leslie Baumann - Baumann Cosmetic Research Institute (BCRI) - joined the SCA team

LONG BEACH, Calif., Nov. 6, 2019 /PRNewswire/ -- The Spine Ce

MARLBOROUGH, Mass., Nov. 6, 2019 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) announced the pricing of a public offering of €900,000,000 aggregate principal amount of its 0.625% notes due 2027, under the Company's shelf registration statement. The Company expects to receive the net offering proceeds upon closing on

NEW YORK, Nov. 6, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Northern District of Ohio on behalf of all investors that purchased ViewRay, Inc. (N

CUPERTINO, Calif., Nov. 6, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it will host a key opinion leader (KOL) conference call and live webcast to discuss the

HOLLISTON, Mass., Nov. 6, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG), a bioengineering company developing next-generation esophageal implants, announced today that it will report its financial results for the three and nine months ended September 30, 2019 in a press release that will be issued pre-market on

MONMOUTH JUNCTION, N.J., Nov. 6, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its